GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cellyan Biotechnology Co HKPD · USD

Industrials · US listing · 🇺🇸 United States

Compare

1.53

+5.17%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Cellyan Biotechnology Co

Its shares trade under the ticker HKPD. It has been listed since 15 January 2025. In the fiscal year to 31 March 2026, it reported revenue of $13.4m and a net loss of $1.1m. At that date it held total assets of $12.8m and shareholders' equity of $9.6m.

Hong Kong Pharma Digital Technology Holdings Ltd is a HK-based company operating in Air Freight & Logistics industry. Hong Kong Pharma Digital Technology Holdings Ltd is an investment holding company mainly engaged in the over the counter (OTC) pharmaceutical business. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Industrials
Industry
Air Freight & Logistics
Listed since
15 Jan 2025
Website
9zt.hk ↗
Head office
ROOM B1, 5/F. WELL TOWN IND. BUILDING, KOWLOON
Incorporated in
E9
Classification
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Filer status
Non-accelerated filer<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Lap Sun WongChairman of the Board, Chief Executive Officer, since 2023
  • Mr. Man Bun KwokChief Financial Officer
  • Ms. Yingying LiChief Operating Officer
  • Mr. Zhifang ZhangDirector
  • Mr. Kam Leung ChanIndependent Director Nominee
  • Dr. King Yin LaiIndependent Director Nominee
  • Ms. Raina ZouIndependent Director Nominee

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company operates in the Air Freight & Logistics industry with a focus on OTC pharmaceutical supply chain services.
  • Provides cross-border e-commerce supply chain services for OTC pharmaceuticals.
  • Offers procurement and distribution services for OTC pharmaceuticals across borders.

Weaknesses

  • Company is an investment holding company with unclear operational details.
  • City location is listed as unknown, indicating potential lack of transparency.
  • IPO date is set for 2025-01-15, suggesting the company is not yet publicly traded.

Opportunities

  • Growing demand for cross-border pharmaceutical e-commerce services.
  • Potential expansion into new markets for OTC pharmaceutical supply chain solutions.
  • Increasing global trade in pharmaceuticals could benefit the company's services.

Threats

  • Untrusted source description may lead to inaccurate information about the company's operations.
  • Company is not yet publicly traded, which may limit investor confidence.
  • Industry competition in logistics and pharmaceutical supply chain services is intense.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.